Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal Dexmedetomidine and Ketamine for Rescue Pediatric Sedation
NCT04822064Recruiting
- Sponsor
- Seoul National University Hospital
- Start
- Sep 2022
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of dexmedetomidine and ketamine in Procedural sedation (PS), sponsored by Seoul National University Hospital. Primary endpoint: Success rate of adequate rescue sedation (PSSS = 1, 2, 3) within 15 minutes. Started Sep 2022; status: recruiting.
02
Drugs
dexmedetomidineketamine
03
Conditions
Procedural sedation (PS)
Beyond the preview
Go deeper on NCT04822064.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04822064.